Top section
Top section
◆ The threat of US corporate issuance to European borrowers ◆ The new funding environment for Middle East banks ◆ Reviving UK equity capital markets
Swiss investors retain appetite for credit as yields become more attractive
As war drags on, banks are boosting hoards of cash after deposit outflows
Data
More articles
More articles
More articles
-
The onshore arm of DBS bagged Rmb3bn ($448.3m) from the Chinese bond market on Tuesday, marking its first trade since 2015 that carries a tenor of more than one year. The transaction was also the second bond from a Singaporean lender in the mainland this year. -
Chinese firm Ascletis Pharma has launched bookbuilding for a HK$3.58bn ($456.9m) IPO, the first company to take advantage of the Hong Kong Stock Exchange’s new biotechnology-friendly listing regime.
-
The Hong Kong Stock Exchange and China’s two largest bourses have reached a consensus on when dual-class share companies can be included on the Stock Connect, following a surprise decision by the latter to exclude weighted voting rights (WVR) shares from the southbound channel of the cross-border trading system.
-
CanSino Biologics, founded by a group of Chinese vaccination industry experts from Canada, has filed for a listing in Hong Kong.
-
HSBC has hired Seok Kheng Yap, a former loans banker at Scotiabank, as an associate director in the loan syndications team.
-
South Africa’s Investec Bank has doubled the size from launch of its two year syndicated term loan to $600m, after a 'significant' oversubscription.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
